BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16532107)

  • 1. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT; Al-Qudah MA
    Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
    Nilesh K; Dharamsi R; Patil P; Mate P
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial.
    de Souza Nobre BB; Rezende L; Barbosa Câmara-Souza M; Sanchez-Ayala A; Blass R; Carbone AC; Manso AC; Ernberg M; Christidis N; De la Torre Canales G
    Sci Rep; 2024 Jun; 14(1):14522. PubMed ID: 38914688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
    Lee JS; Son HS; Kim BJ; Lee YW
    Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical masseteric bulging after botulinum neurotoxin type A injection.
    Sandhu S; Shaefer J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study.
    Seok J; Koh YG; Hong JK; Yun SH; Kim DH; Son HS; Choi SY; Yoo KH; Lee YW; Kim BJ
    Dermatol Surg; 2024 Jun; 50(6):527-533. PubMed ID: 38518110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and esthetic effects of botulinum toxin injection into the masseter muscles: evaluation of 80 patients from a dermatological perspective.
    Ozdemir Cetinkaya P; Karaosmanoglu N; Özkesici Kurt B; Aksu Cerman A; Altunay IK
    Int J Dermatol; 2024 Jun; ():. PubMed ID: 38837386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulator Finesse for Masseter Hypertrophy and Bruxism.
    Chiodo MV; Lisiecki JL; Rohrich RJ
    Plast Reconstr Surg; 2024 Apr; 153(4):726e-729e. PubMed ID: 37224448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can previously injected botulinum toxin cause paradoxical masseter muscle rigidity after administration of a nondepolarizing neuromuscular blocking agent?
    Lee JY; Seo KH
    Can J Anaesth; 2024 Feb; 71(2):294-295. PubMed ID: 37853281
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of unilateral masseter hypertrophy and hypertrophic scar-a case report.
    Shetty N; Malaviya RK; Gupta MK
    Case Rep Dent; 2012; 2012():521427. PubMed ID: 22844620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of masseteric hypertrophy and mandibular retrognathism.
    Singh S; Shivamurthy DM; Agrawal G; Varghese D
    Natl J Maxillofac Surg; 2011 Jan; 2(1):96-9. PubMed ID: 22442621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
    Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for masseter hypertrophy.
    Fedorowicz Z; van Zuuren EJ; Schoones J
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle.
    Kim NH; Park RH; Park JB
    Plast Reconstr Surg; 2010 Jun; 125(6):1693-1705. PubMed ID: 20517093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J; Hsu SH; McGee JS
    Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating Idiopathic Masseter Muscle Hypertrophy in a 14-Year-Old Female Child: A Report of a Unique Case.
    Javvaji CK; Vagha K; Vagha JD; Desale R; Uke P; Varma A; Kommareddy A; Damam S; Reddy NS
    Cureus; 2024 Jan; 16(1):e52792. PubMed ID: 38389625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic masseter muscle hypertrophy: a case report.
    Antunes JJ; Almeida SA; Monteiro RMPC; Martins AM
    Einstein (Sao Paulo); 2019 Mar; 17(2):eAI4506. PubMed ID: 30843993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.